Notably, unlike β-catenin and APC mutations in colon cancer, these mutations are very rare in NSCLC20, 21; thus, understanding the biological basis for the observed deregulation of Wnt overactivation is of great value for future development of novel therapeutic strategies. Here, APC is linked to malignant colon neoplasm.